OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent updates on the management of autoimmune hepatitis
Atsumasa Komori
Clinical and Molecular Hepatology (2020) Vol. 27, Iss. 1, pp. 58-69
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

FGF4 improves hepatocytes ferroptosis in autoimmune hepatitis mice via activation of CISD3
Huimian Jiang, Yan Fang, Yuxin Wang, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109762-109762
Open Access | Times Cited: 27

The Role of Red Cell Distribution Width as a Prognostic Marker in Chronic Liver Disease: A Literature Review
Hunain Aslam, Fouzia Oza, Khalid Ahmed, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3487-3487
Open Access | Times Cited: 24

Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases
Arianna Ferro, Gabriele Saccu, Simone Mattivi, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 277-277
Open Access | Times Cited: 14

Mesenchymal Stem Cell–Derived Exosomes in Various Chronic Liver Diseases: Hype or Hope?
Lujian Zhu, Qing K. Wang, Maodong Guo, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 171-189
Open Access | Times Cited: 10

Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases
Liuting Zeng, Kailin Yang, Ganpeng Yu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 9

A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases
Lynn Khoon, Ron Piran
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 410-410
Open Access | Times Cited: 1

Allyl methyl disulfide attenuates liver injury induced by concanavalin A by suppressing M1 polarization of macrophages and NLRP3 inflammasome activation
Mingjie Song, Xuan Gao, Dongmei Cheng, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114149-114149
Closed Access | Times Cited: 1

Value of Liver Function Tests in Cirrhosis
Praveen Sharma
Journal of Clinical and Experimental Hepatology (2021) Vol. 12, Iss. 3, pp. 948-964
Open Access | Times Cited: 46

Nutraceutical Properties of Syringic Acid in Civilization Diseases—Review
Iga Bartel, Izabela Mandryk, Jarosław Olav Horbańczuk, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 10-10
Open Access | Times Cited: 17

Targeting Glutamine Metabolism Ameliorates Autoimmune Hepatitis via Inhibiting T Cell Activation and Differentiation
Qiang Yu, Honghu Tu, Xueyi Yin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27

Autoimmune Hepatitis and Fibrosis
Rinaldo Pellicano, Arianna Ferro, Francesca Cicerchia, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1979-1979
Open Access | Times Cited: 14

AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV infection
Xiaohuan Lai, Haiyan Chen, Dong Xiao-feng, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 3, pp. 338-344
Open Access | Times Cited: 5

Engineering M2 type macrophage-derived exosomes for autoimmune hepatitis immunotherapy via loading siRIPK3
Lu Zhang, Man Liu, Qiu Sun, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116161-116161
Open Access | Times Cited: 4

Autoimmune Disorders: Types, Symptoms, and Risk Factors
Saurav Kumar, Dhirender Kaushik, S.K. Sharma
Studies in computational intelligence (2024), pp. 3-31
Closed Access | Times Cited: 4

Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis
Atsumasa Komori
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 157-159
Open Access | Times Cited: 4

An atypical presentation of autoimmune hepatitis with delayed menarche in a Nigerian adolescent: a case report
Promise Asogwa, Bruno Basil, Winifred Njideka Adiri, et al.
Journal of Medical Case Reports (2025) Vol. 19, Iss. 1
Open Access

Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations
Chaojie Yu, Wenrui Wang, Qian Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

IRG1/itaconate enhances efferocytosis by activating Nrf2-TIM4 signaling pathway to alleviate con A induced autoimmune liver injury
Liwu Zeng, Yaxin Wang, Yongzhou Huang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

Disulfiram alleviates immune-mediated liver injury by inhibiting pyroptosis in hepatocytes through the NF-κB pathway
Wanyuan Xiong, Junfeng Li, Xiaorong Mao, et al.
European Journal of Pharmacology (2025) Vol. 992, pp. 177352-177352
Closed Access

Real-world pharmacovigilance study of drug-induced autoimmune hepatitis from the FAERS database
Bukun Zhu, Siying Chen, Xiang Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Cholestatic Phenotype in Autoimmune Hepatitis: A Rare Presentation
V. Srinath, Fatima Shahid, Muhammad Nabeel Saddique, et al.
Digestive Diseases and Sciences (2025)
Closed Access

Sensitivity and stability of Balb/c, C57BL/6J, and ICR mice to the acute liver injury induced by concanavalin A
Mingjie Song, Xuan Gao, Ruirui Kou, et al.
Toxicology Research (2025) Vol. 14, Iss. 2
Closed Access

Page 1 - Next Page

Scroll to top